Literature DB >> 5575564

Effect of chlorite-oxidized oxyamylose on influenza virus infection in mice.

A Billiau, J J Muyembe, P De Somer.   

Abstract

Intraperitoneally administered chlorite-oxidized oxyamylose (COAM) provided protection of mice against intranasal infection with several influenza virus strains. Treated animals invariably showed a reduced consolidation of the lungs and, in the case of infection with lethal strains of virus, also a delay in mortality. With a small dose of influenza A/PR8 virus, an increase in final survival rate could be observed. The effect of COAM on influenza virus infection lasted for at least 4 to 8 days. Inhibition of lung consolidation was not paralleled by a decrease in virus multiplication in the lung. The significance of this finding in relation to the mechanism of the antiviral action of COAM is discussed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5575564      PMCID: PMC377234          DOI: 10.1128/am.21.4.580-584.1971

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  3 in total

1.  Inducers of interferon and host resistance. VI. Antiviral efficacy of poly I:C in animal models.

Authors:  M M Nemes; A A Tytell; G P Lampson; A K Field; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1969-11

2.  Polyacetal carboxylic acids: a new group of antiviral polyanions.

Authors:  P Claes; A Billiau; E De Clercq; J Desmyter; E Schonne; H Vanderhaeghe; P De Somer
Journal:  J Virol       Date:  1970-03       Impact factor: 5.103

3.  Antiviral activity of chlorite-oxidized oxyamylose, a polyacetal carboxylic acid.

Authors:  A Billiau; J Desmyter; P De Somer
Journal:  J Virol       Date:  1970-03       Impact factor: 5.103

  3 in total
  1 in total

1.  Suppression of extablished Friend virus leukemia by statolon: potentiation of statolon's leukemosuppressive activity by chlorite-oxidized oxyamylose.

Authors:  O S Weislow; E F Wheelock
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.